Ocular Therapeutix vs Siga Technologies
Siga Technologies is the larger business, with $94.6m of revenue in fiscal 2025 against $52.0m for Ocular Therapeutix (1.8 times as much). Ocular Therapeutix grew faster (-18.5% against -31.8%). Siga Technologies kept more of each dollar of sales as profit: a net margin of 24.6% against -511.9%. Siga Technologies carries less debt relative to equity (0.0% against 10.9%).
| Latest fiscal year | Ocular TherapeutixOCUL, 2025 | Siga TechnologiesSIGA, 2025 |
|---|---|---|
| Revenue | $52.0m | $94.6m |
| Revenue growth | -18.5% | -31.8% |
| Net income | −$266m | $23.3m |
| Operating margin | -519.8% | 25.1% |
| Net margin | -511.9% | 24.6% |
| Return on equity | -54.9% | 11.2% |
| Free cash flow | −$217m | $43.1m |
| Cash | $737m | $155m |
| Total debt | $71.3m | $0 |
| Debt to equity | 10.9% | 0.0% |
| Dividend per share | — | $0.60 |
| Dividend yield | — | 20.6% |
| Share buybacks | — | $0 |
| Employees | 325 | 49 |
| Market value | $1.52bn | $222m |
| Price vs our value range | — | Below our value range |
| Moat score | 17 (Weak) | 71 (Strong) |
| Insider trades, 12 months | 1 buys, 29 sales | 0 buys, 0 sales |